13 research outputs found
Cerebral blood flow velocity in migraine and chronic tension-type headache patients.
The present study seeks to use transcranial Doppler ultrasound to evaluate cerebral blood flow velocities in anterior and posterior circulation arteries, during an attack-free episode in migraine patients, with and without aura, as well as in chronic tension-type headache patients who were not receiving prophylactic medication
A Case of Multiple Sclerosis and Celiac Disease
Objectives. Multiple sclerosis (MS) is an inflammatory autoimmune disorder of the central nervous system (CNS). Since a correlation between gluten intake and incidence of MS had been reported, the relationship of antigliadin antibodies and MS was debated. Case Report. We report the case of a 45-year-old female MS patient who is under interferon treatment. After seven years of monitoring, during her routine gastroenterological assessment, she was diagnosed with celiac disease. Conclusion. Beside the neurological manifestations that have been demonstrated in about 10% of celiac disease (CD) patients, white-matter abnormalities in brain MRI are uncommon and controversial. But in the literature, MS seems to be associated with CD as in our patient. We suggest that MS patients with gastroenterological complaints should undergo an assessment for CD
Cerebral blood flow velocity in migraine and chronic tension-type headache patients
Introduction: The present study seeks to use transcranial Doppler
ultrasound to evaluate cerebral blood flow velocities in anterior and
posterior circulation arteries, during an attack-free episode in
migraine patients, with and without aura, as well as in chronic
tension-type headache patients who were not receiving prophylactic
medication. Methods: A total of 50 patients (35 female, 15 male) were
evaluated during a headache-free episode: 30 migraine patients without
aura (mean age: 32 +/- 8 years), 10 migraine patients with aura (mean
age: 34 +/- 4 years), and 10 patients with chronic tension-type headache
(mean age: 34 +/- 5 years). Results: No significant difference was
present between anterior, middle, and posterior cerebral and vertebral
arteries' blood flow velocities between migraine patients, with and
without aura, or in patients with a tension-type headache, and normal
controls (p>0.05). However, a significant increase in basilar artery
cerebral blood flow velocities relative to controls was present in
patients with a tension-type headache (p>0.001). Conclusion: It is
difficult to predict the main reason for the significant increase in
basilar artery blood flow velocities in patients with chronic
tension-type headache. It may be due to constriction of conductance or
the dilatation of the resistance vessels
Iron-Deficiency Anemia Leading to Transient Ischemic Attacks due to Intraluminal Carotid Artery Thrombus
Reactive thrombocytosis secondary to iron-deficiency anemia (IDA) is a rare but recognized cause of stroke. We report the case of a patient with iron-deficiency anemia presenting with multiple transient ischemic attacks (TIA) due to intraluminal thrombus of an internal carotid artery. The putative mechanisms underlying anemia and stroke syndromes are not completely understood, and it is believed that iron deficiency may cause ischemic stroke by several potential mechanisms. Thrombocytosis is often associated with iron deficiency, and microcytosis produces a reduction in the red cell deformability and could produce a hypercoagulable state. The platelet count and function observed in iron-deficiency anemia could act synergistically to promote thrombus formation, especially in the setting of an underlying atherosclerotic disease. The presence of floating thrombus in a patient with clinical and MRI evidence of stroke represents a significant therapeutic dilemma and requires immediate decision about treatment
The probable role of insulin resistance and SIRT1 proteins in the Alzheimer's disease
Objective: Recent evidence suggests that insulin resistance may play an
important role in the pathogenesis of Alzheimer's disease (AD). In this
study, the probable role of insulin resistance in the pathogenesis of AD
was investigated in patients with Type 2 Diabetes Mellitus (T2DM).
Methods: Serum amyloid beta (A beta) (1-42), insulin like growth
factor-1 (IGF-1), sirtuin1 (SIRT1) and leptin protein levels were
measured in serum samples of control (n = 26), probable AD (n = 26), and
probable AD+T2DM patients (n = 12) using ELISA method. Mini mental state
examination (MMSE) was performed to the patient and control groups.
Result: Serum IGF-1 significantly increased in the probable AD+T2DM
group as compared to the control and probable AD groups (p < 0.05). The
levels of serum leptin significantly decreased in the probable AD and
AD+T2DM groups as compared to the control (p < 0.05). There were no
statistically significant differences in serum A beta (1-42) and SIRT1
levels among groups (p > 0.05).
Conclusion: The significant decrease in serum leptin levels in AD
patients may indicate that it may be a therapeutic marker in AD. The
level of serum A beta peptide and SIRT1 proteins can vary depending on
the stage of the disease. Therefore, this study should be supported by
more comprehensive studies in terms of the number of patients in
advanced stage (Tab. 1, Fig. 4, Ref. 29)
Olfactory functioning in early multiple sclerosis : Sniffin' sticks test study
Introduction: Previous studies have shown that olfactory functioning is
affected by multiple sclerosis (MS). This study assessed the level of
the olfactory impairment in early MS by using the Sniffin' Sticks Test.
Methods: This study included 30 patients with MS and 30 healthy
controls. We collected demographic and clinical data from participants
and administered the Sniffin' Sticks Test.
Results: We found no differences between the MS and control groups in
odor discrimination, odor identification, and threshold discrimination
identification scores, but odor threshold (OT) scores were higher in the
control group than in the MS group (P= 0.49). In addition, we did not
find any correlation between MS patients' olfactory test scores and
their scores on the Mini-Mental State Examination (MMSE), Expanded
Disability Status Scale (EDSS), disease duration, history of optic
neuritis, or being on immunomodulatory therapy.
Conclusion: In recent studies, odor threshold impairment seemed to be
the most striking finding in patients with MS. Although the present
study found a mild alteration in odor threshold, olfactory dysfunction
appears to be a consequence of neurodegeneration in the higher order
olfactory brain regions, which is thought to be a time-dependent
process